Three-Year Outcomes After Bifurcation Stenting With Zotarolimus-Eluting Stents: Final Results From the RESOLUTE ONYX Postapproval Study

Matthew J. Price,Loukas Boutis,Ajay J. Kirtane,Stanley Chetcuti,Petra Poliačiková,Joseph Dens,Michael Attubato,Yale Wang,Patrick Hu,Douglas Spriggs,Joshua Krasnow,Yiannis Chatzizisis,Adel Aminian,Ronald Caputo,Alpesh Shah,Michelle Dauler,Sherif Ibrahim,Te-Hsin Lung,Roxana Mehran

Journal of the Society for Cardiovascular Angiography & Interventions（2023）

引用 0|浏览7

暂无评分

摘要

•Resolute Onyx was safe and effective for provisional stenting of bifurcation lesions.•There were no episodes of stent thrombosis associated with target lesions at 3 years.•Only 6% of patients required clinically driven target-lesion revascularization.

查看译文

关键词

bifurcation,drug-eluting stent,percutaneous coronary intervention,zotarolimus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要